Related Experiment Video

Updated: Jul 5, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.6K

The Impact of miR-122 on Cancer

Shijie Wu1, Yiwen Wu1, Sijun Deng1

  • 1School of Pharmaceutical Science, Hengyang Medical College, University of South China, Hengyang, Hunan, P.R. China.

Current Pharmaceutical Biotechnology
|January 23, 2024
PubMed

Insights

MicroRNAs (miRNAs), like miR-122, regulate gene expression and are crucial in cancer development. Dysregulated miR-122 shows potential as a biomarker for cancer diagnosis and therapy.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) are short, conserved noncoding RNAs regulating gene expression post-transcriptionally.
  • Dysregulated miRNAs function as oncogenes or tumor suppressors in various cancers.
  • miR-122 is implicated in carcinogenicity across multiple tumor types by modulating target genes and pathways.

Purpose of the Study:

  • To review the role of miR-122 in gene regulation and tumor biology.
  • To discuss the impact of miR-122 dysregulation in human malignancies.
  • To explore the potential of miR-122-targeted therapies and its utility as a biomarker.

Main Methods:

  • Literature review focusing on miR-122 expression and function in cancer.
  • Analysis of studies investigating miR-122's regulatory mechanisms and impact on oncogenesis.
  • Synthesis of evidence regarding miR-122's role in various human cancers.

Main Results:

  • miR-122 significantly influences carcinogenicity by regulating target genes and signaling pathways.
  • Dysregulation of miR-122 is observed in diverse human malignancies.
  • miR-122 exhibits potential as a diagnostic and therapeutic biomarker in oncology.

Conclusions:

  • miR-122 plays a critical role in cancer development and progression.
  • Targeting miR-122 offers potential for novel cancer therapies.
  • Combining miR-122 with traditional biomarkers may improve cancer diagnosis and patient outcomes.
Keywords:
biological processesbiomarkercancermiR-122molecular mechanismpolyadenylation signal.tumorigenesis

More Related Videos

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

17.6K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

385

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K